Advantages and Mass Balance Results Dosing [14C]-Oncology Drugs to Normal Healthy Volunteers: Compiled Data from 22 AME Studies

Time

Tue, Jun 25 11:45AM
T 18

Title

Advantages and Mass Balance Results Dosing [14C]-Oncology Drugs to Normal Healthy Volunteers: Compiled Data from 22 AME Studies

Abstract Summary

[14C]-oncology drugs were dosed in NHVs for 16 different Pharma by Covance CRU, approved by an IRB and radiation safety committee. NHVs were consented prior to any study-related procedures. Subjects were confined until discharge criteria were met based on “real-time” radioanalysis at Covance Labs.

Poster Presenter

Robert George Kochan
PhD,
US Clinical Pharmacology Radiation Safety Officer,
Covance Clinical Development Services
United States

© 2015 DIA